ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

In the States: Georgia Requires Coverage Of Routine Costs For Children In Clinical Trials

August 14, 1998

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

Knowing Tumor Cell Structure Improves Treatment Decisions

March 27, 2009

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007